Cite
Clinical impact of bile-derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers.
MLA
Yoshida, Michihiro, et al. “Clinical Impact of Bile-Derived Exosomal MicroRNAs as Novel Diagnostic and Prognostic Biomarkers for Biliary Tract Cancers.” Cancer Science, vol. 114, no. 1, Jan. 2023, pp. 295–305. EBSCOhost, https://doi.org/10.1111/cas.15597.
APA
Yoshida, M., Yukawa, H., Hayashi, K., Naitoh, I., Miyabe, K., Hori, Y., Natsume, M., Jinno, N., Kato, A., Kachi, K., Asano, G., Sahashi, H., Toyohara, T., Kuno, K., Kito, Y., Kondo, H., Hirano, A., Okumura, F., Anbe, K., … Tanaka, Y. (2023). Clinical impact of bile-derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers. Cancer Science, 114(1), 295–305. https://doi.org/10.1111/cas.15597
Chicago
Yoshida, Michihiro, Hiroshi Yukawa, Kazuki Hayashi, Itaru Naitoh, Katsuyuki Miyabe, Yasuki Hori, Makoto Natsume, et al. 2023. “Clinical Impact of Bile-Derived Exosomal MicroRNAs as Novel Diagnostic and Prognostic Biomarkers for Biliary Tract Cancers.” Cancer Science 114 (1): 295–305. doi:10.1111/cas.15597.